Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
JYNT · 10-Q filed May 7, 2026

JYNT earnings analysis

What we found in JYNT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The Joint Corp. reported a strong Q1 2026 performance with revenue of $14.8 million, representing a 13.3% increase year-over-year, and an EPS of $0.08, surpassing estimates. The results reflect improved operational efficiency and continued focus on franchising, despite external challenges such as labor shortages and economic volatility.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Growth of 13.3%
Total revenue increased to $14.82 million from $13.08 million year-over-year.
EPS Exceeds Estimates
Reported EPS reached $0.08, beating the estimated EPS of $0.03.
Improved Operating Income
Income from operations increased to $873,668 from a loss of $678,534, a $1.55 million improvement.
Cost of Revenues Decreased 8.4%
Total cost of revenues fell to $2.72 million from $2.97 million, enhancing margins.
Strong Franchise Fees Growth
Franchise fees rose 38.2% to $1.14 million from $0.83 million, driven by terminated license agreements.
Increase in Advertising Fund Revenue
Advertising fund revenue surged 58.1% to $3.65 million from $2.31 million.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Labor Shortages Persist
Ongoing labor shortages continue to impact clinic operations and could affect service quality.
Comp Sales Decline
Comp sales decreased by 4.2% for clinics open for over 13 months.
Economic Volatility Risks
Persistent economic uncertainties and elevated interest rates could influence customer spending.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$0.08
Guidance

What they said about what is next.

2026 system-wide sales guidance reiterated as previously stated.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing JYNT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever